Treatment of Urinary Tract Infections (UTIs)
For uncomplicated UTIs in adults, first-line treatment options include nitrofurantoin 100mg twice daily for 5 days, trimethoprim-sulfamethoxazole 160/800mg twice daily for 3 days, or fosfomycin 3g as a single dose. 1
Diagnosis Before Treatment
- Obtain a urine specimen for culture prior to initiating antimicrobial therapy to identify the infecting organism and determine antimicrobial resistance 1
- A high colony count (>100,000 cfu/ml) in a urine culture suggests true infection 1
- Differentiate between colonization and true infection before initiating treatment 1
Treatment Algorithm for UTIs
Uncomplicated UTIs in Women
First-line options (in order of preference):
Second-line options:
Reserve fluoroquinolones (e.g., ciprofloxacin) for more invasive infections due to increasing resistance rates and potential side effects 1, 4
Complicated UTIs
- Treatment duration: 7-10 days 1
- Parenteral options for severe infections:
Catheter-Associated UTIs
- If catheter has been in place ≥2 weeks and is still needed, replace the catheter before collecting specimen and initiating treatment 1
- Obtain urine culture specimens from freshly placed catheters prior to initiating antimicrobial therapy 1
- Discontinue urinary catheters as soon as possible 1
Special Populations
Postmenopausal Women with Recurrent UTIs
Premenopausal Women with Post-Coital Infections
- Consider low-dose antibiotic prophylaxis within 2 hours of sexual activity for 6-12 months 5
Men with UTIs
- Limited evidence supports 7-14 days of therapy 4
Diabetic Women
- Treat similarly to women without diabetes if no voiding abnormalities are present 4
Treatment Monitoring and Follow-up
- Monitor clinical response within 72 hours of initiating therapy 1
- If no improvement occurs, consider:
- Extending treatment duration
- Performing urologic evaluation
- Adjusting antimicrobial regimen based on culture and susceptibility results 1
Prevention of Recurrent UTIs
- Non-antimicrobial measures:
Common Pitfalls to Avoid
Treating asymptomatic bacteriuria: Should not be treated, especially in elderly patients, as this does not improve outcomes and contributes to antibiotic resistance 1
Overuse of fluoroquinolones: High rates of resistance preclude their use as empiric treatment in many communities, particularly in patients recently exposed to them or at risk of infections with ESBL-producing bacteria 3
Inadequate treatment duration: Too short a course may lead to treatment failure, while unnecessarily long courses contribute to antibiotic resistance 5, 1
Failure to narrow antibiotic spectrum: Once culture results are available, therapy should be targeted to the specific organism to reduce the risk of developing resistance 5, 3
Not considering local resistance patterns: Treatment should take into account local antibiograms when selecting empiric therapy 5, 4